News Releases

Click here to access press releases from Astellas Pharma Inc. located in Tokyo, Japan.

Month Year

Jun 27, 2005

OSI Pharmaceuticals Announces that Tarceva-R- Receives Positive Opinion in EU for the Treatment of Patients with Advanced Lung Cancer
Jun 2, 2005

OSI Pharmaceuticals Announces Issuance of Additional U.S. Patent for Tarceva; Extends Patent Exclusivity
May 27, 2005

Astellas and Item File Lawsuit Against Adenoscan® Generic For Patent Infringement in the USA
May 24, 2005

New Studies of Immunosuppressive Regimens Limiting or Avoiding the Use of Steroids Show Excellent Graft Survival in Transplant Recipients on a Prograf®-Based (Tacrolimus) Regimen

One Study of Early Steroid Withdrawal Reduced Cholesterol Levels and Decreased Onset of Post Transplant Diabetes
May 24, 2005

Three Clinical Studies Demonstrate Once-Daily Modified Release Prograf® Formula to be Promising Treatment Option

Additional Milligram to Milligram Conversion Study Shows Equivalency of Prograf to MR Prograf
May 17, 2005

Data from Tarceva Clinical Trial Program Presented at American Society of Clinical Oncology Annual Meeting
May 16, 2005

Data from Tarceva-TM- Clinical Trial Program Presented at American Society of Clinical Oncology Annual Meeting; EGFR Amplification / Mutation Analysis from the Registration BR.21 Trial Presented
May 14, 2005

Phase III Study of Tarceva in Combination With Chemotherapy Improves Survival in Pancreatic Cancer Patients

Data Presented at Plenary Session at Annual ASCO Meeting
May 12, 2005

Anti-Fungal Agent MYCAMINE™ Available to Physicians

First Astellas Product Launched in the United States
May 2, 2005

OSI Pharmaceuticals and Genentech Announce Filing of a Supplemental New Drug Application to the FDA for Tarceva -TM- in Pancreatic Cancer

Show per page

Statements

Careers

Stay Connected

Get only the email alerts you want.

Media Contacts

For media inquiries and reporter requests, please email us at corporate.communications@us.astellas.com.

Our communications team will respond to verified media requests within 24-48 hours as appropriate.

If you are not a reporter and need assistance, please visit our contact us page that includes information for patients, healthcare providers and researchers.

Download Fact Sheet

Sustainability

Investors

Explore U.S. Products

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa

News Releases

You are now leaving XTANDI.com

You are now leaving newsroom.astellas.com.